Stem Cell Clinical Trials in Hangzhou, Zhejiang
7 recruitingHangzhou, Zhejiang, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
VenentoclaxALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONMyeloid Malignancies+3 more
First Affiliated Hospital of Zhejiang University186 enrolled18 locationsNCT07396480
Recruiting
Not Applicable
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
PreventionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang266 enrolled4 locationsNCT06198517
Recruiting
Phase 3
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
ThrombocytopeniaHematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University404 enrolled1 locationNCT07442513
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell TransplantationCardiovascular EventsTransplant Complication
Peking University People's Hospital10,000 enrolled16 locationsNCT07349498
Recruiting
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Non-Hodgkin's LymphomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled17 locationsNCT06520163
Recruiting
Phase 3
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Multiple MyelomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled16 locationsNCT06520176
Recruiting
Phase 2
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University95 enrolled1 locationNCT04809181